Clinical Trials on Renal Insufficiency, Chronic in Liechtenstein
Total 2 results
-
Ivoclar Vivadent AGRecruitingInsufficient Dental Filling or Primary Caries (Class I or II Cavities in Premolars or Molars)Liechtenstein
-
NycomedCompleted
Sponsors and Collaborators
- InflaRx GmbH
- Mononuclear Therapeutics Ltd.
- Grand Challenges Canada
- Centro di Procreazione Assistita Demetra
- Equipe MiMes
- North Karelia Hospital District
- Maria Lendorf
- Yantai Yuhuangding Hospital，Medical College, Qingdao University
- Prestige Biopharma Limited
- Bruce County Paramedic Service
- Nestor Soler Porcar, MD, PhD
- Chengdu Nuoen Biotechnologies, Inc.
- Reina Sofia University Hospital
- Bjørgene Omsorgssenter, Haugesund
- AIDS Council of New South Wales
- ImproveCareNow (ICN)
- BayCare Health System
- Women and children's hospital of Jiaxing university
- Neuregenix
- Veeda Oncology
- View Full List
Medical Conditions
- Philadelphia Chromosome-positive Chronic Myeloid Leukemia in Chronic Phase
- Childhood Langerhans Cell Histiocytosis
- Fracture Dislocation of Cervical Spine
- Cancers of Non-thoracic Origin With Metastases to the Lungs or Pleura
- Psoriasis, Arthritic
- Closure; Foramen Ovale
- Endocarditis Infective
- Fetus or Neonate Affected by External Version Before Labor
- Chlamydophila Infections
- Painless Hysteroscopy
- Pulmonary Adenocarcinoma
- Skull Base Neoplasms
- Gullian Barre Syndrome
- Tay-Sachs Disease Ganglioside
- Multisystem Proteinopathy
- Cutaneous Leiomyomata With Uterine Leiomyomata
- Epidemic Hemorrhagic Fever
- Ewing's Family Tumors
- Predictors of Atrial Fibrillation Recurrences
- Spine Surgeries
- View Full List
Drug Interventions
- Naltrexone 50 mg/day + Cognitive Behavioral Therapy
- Qingkailing injection 40 ml
- EFV +TVA
- Adapalene Gel 0.3%
- Glimepiride
- Adriamycin
- Redifferentiation with retinoid acid
- Semapimod
- Vehicle
- Estradiol+Drospirenone
- Neihulizumab
- NanoDoce (intravesical instillation) - Induction and Maintenance Instillations
- Esomeprazole 40mg before
- PET/CT using PET ligands [F-18]FDG and [F-18]DPA-714
- Chemotherapeutic Agent
- Palliative care group first-line scheme
- Azelastine hydrochloride (BAYR9258)
- Mocetinostat - Recommended Phase 2 Dose (70 mg)
- High dose pantoprazole infusion
- Cereport
- View Full List
CROs by country
- Contract Research Organizations in Algeria
- Contract Research Organizations in Bahrain
- Contract Research Organizations in Belarus
- Contract Research Organizations in Benin
- Contract Research Organizations in Brazil
- Contract Research Organizations in Burundi
- Contract Research Organizations in Cambodia
- Contract Research Organizations in Cameroon
- Contract Research Organizations in Canada
- Contract Research Organizations in Cyprus
- Contract Research Organizations in Czech Republic
- Contract Research Organizations in Mali
- Contract Research Organizations in Morocco
- CRO list by country